119.98USD-0.35%Mkt Cap: 5.52B $P/E: 222.191d ago
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the sing…
Industry Peers
Diagnostics & Researchvs Diagnostics & Research
P/B
Pricier
1M Perf
Lower
$186.32BUSDP/E 27.6
$134.82BUSDP/E 36.8
$43.51BUSDP/E 42.0
$41.53BUSDP/E 38.7
$38.88BUSD
$37.53BUSDP/E 26.7
$36.82BUSDP/E 47.7
$32.25BUSDP/E 24.0
$26.60BUSDP/E 31.9
$25.82BUSDP/E 30.0
$23.46BUSDP/E 23.4
$22.96BUSDP/E 24.8
$19.89BUSD
$15.12BUSDP/E 33.3
$12.91BUSDP/E 26.9
$12.41BUSDP/E 53.5
$10.92BUSD
$8.81BUSDP/E 20.6
$6.41BUSD
$5.06BUSDP/E 43.3
$4.85BUSD
$4.69BUSDP/E 54.4
$3.65BUSDP/E 25.7
$3.43BUSD
$2.93BUSD
$2.04BUSD
$1.90BUSD
$1.48BUSDP/E 37.4
$1.48BUSDP/E 22.4
$1.47BUSD
$1.40BUSD
$1.13BUSD
$1.01BUSDP/E 21.1
$723.37MUSD
$615.20MUSDP/E 40.1
$582.78MUSD
$539.30MUSD
$297.38MUSDP/E 3.0
$282.06MUSD
$233.52MUSD
$190.51MUSD
$147.80MUSD
$112.34MUSD
$94.30MUSDP/E 18.2
$77.88MUSD
$58.94MUSD
$44.26MUSD
$27.97MUSD
$27.15MUSD
$22.69MUSD
$17.60MUSD
$12.55MUSD
$10.07MUSDP/E 63.2
$9.85MUSD
$9.02MUSD
$8.78MUSD
$6.77MUSD
$6.29MUSD
$5.98MUSD
$5.10MUSD
$4.66MUSD
$3.81MUSD
$3.86MUSDP/E 2.8
$2.93MUSD
$2.79MUSD
$2.43MUSD
$1.29MUSD
$314.2KUSDP/E Infinity
$14.0KUSD
Indicators:|
Key Statistics
Company
Market Cap5.52B $
Enterprise Value5.13B $
Revenue (TTM)354.54M $
Gross Profit208.46M $
Net Income (TTM)7.45M $
Revenue/Share14.31 USD
Last Price119.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees713
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)222.19
P/E (Forward)116.49
PEG—
EV/EBITDA119.12
EV/Revenue14.46
P/S15.57
P/B10.91
EPS (TTM)0.54
EPS (Forward)1.03
52W Range
61.9676% of range138.70
52W High138.70 USD
52W Low61.96 USD
Profitability
Gross Margin68.32%
Oper. Margin16.45%
EBITDA Margin12.14%
Profit Margin2.44%
ROE1.55%
ROA1.18%
Growth
Revenue Growth83.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF24.59M $
CapEx (TTM)8.92M $
FCF Margin4.72%
FCF Yield0.30%
Net Debt-393.26M $
Net Debt/EBITDA-9.14
Balance Sheet
Debt/Equity0.23
Current Ratio10.92
Quick Ratio10.47
Book Value/Sh11.00 USD
Cash/Share11.69 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)117.71 USD
Upside (mean)-1.9%
Target Range90.00 USD – 145.00 USD
$90.00-1.9% to mean$145.00
# Analysts7
Ownership
Shares Out.41.44M
Float24.06M
Insiders46.84%
Institutions37.32%
Short Interest
Short Ratio2.4d
Short % Float7.24%
Short % Out.3.93%
Shares Short1.81M
Short (prev mo.)1.47M
Technical
SMA 5092.58 (+29.6%)
SMA 20089.92 (+33.4%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)713.32K
Avg Vol (10d)852.54K
Technical Indicators
RSI (14)68.8
MACD6.8235
MACD Signal5.2023
MACD Hist.+1.6213
BB Upper119.90 USD
BB Middle104.18 USD
BB Lower88.47 USD
BB Width30.17%
ATR (14)7.086 USD
Vol Ratio (20d)0.66x